CNE100003NL9
CNE100003NL9
BLOOMAGE BIOTECHNOLOGY CORPORAT
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 16.8B EUR | 17.23B EUR | 19.7B EUR |
Enterprise Value | 16.02B EUR | 16.85B EUR | 19.09B EUR |
Valuation Multiples | |||
Trailing P/E | 74.21x | 55.32x | 60.58x |
Forward P/E | 40.09x | -- | -- |
Price to Sales | 4.55x | 4.33x | 4.77x |
Price to Book | 2.35x | 2.43x | 2.76x |
EV/Revenue | 4.34x | 4.24x | 4.63x |
EV/EBITDA | 37.95x | 39.39x | 38.61x |
Price to FCF (P/FCF) | 42.27x | 22.82x | 62.52x |
EV/FCF | 40.31x | 22.32x | 60.59x |
FCF Yield | 2.37% | 4.38% | 1.6% |